BSE Live
Feb 02, 16:01Prev. Close
407.00
Open Price
410.00
Bid Price (Qty.)
402.10 (2)
Offer Price (Qty.)
423.00 (1)
NSE Live
Feb 02, 15:56Prev. Close
408.20
Open Price
409.40
Bid Price (Qty.)
402.20 (10)
Offer Price (Qty.)
0.00 (0)
Quarterly Results of Aarti Drugs (in Rs. Cr.) | Dec '22 | Sep '22 | Jun '22 | Mar '22 | Dec '21 | |
Net Sales/Income from operations | 625.53 | 624.83 | 551.20 | 641.48 | 593.21 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | 625.53 | 624.83 | 551.20 | 641.48 | 593.21 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 401.46 | 435.56 | 430.03 | 436.86 | 387.81 | |
Purchase of Traded Goods | 13.75 | 13.17 | 12.66 | 15.12 | 12.96 | |
Increase/Decrease in Stocks | 23.67 | -15.16 | -59.90 | -11.98 | -13.79 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 19.15 | 17.93 | 16.81 | 18.07 | 17.60 | |
depreciat | 11.87 | 11.92 | 11.83 | 11.88 | 11.95 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 98.52 | 103.15 | 96.87 | 99.31 | 97.95 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 57.11 | 58.26 | 42.90 | 72.22 | 78.73 | |
Other Income | 0.97 | 0.09 | 0.24 | 0.62 | 1.62 | |
P/L Before Int., Excpt. Items & Tax | 58.08 | 58.35 | 43.14 | 72.84 | 80.35 | |
Interest | 9.12 | 8.27 | 6.79 | 5.84 | 5.00 | |
P/L Before Exceptional Items & Tax | 48.96 | 50.08 | 36.35 | 67.00 | 75.35 | |
Exceptional Items | -- | -- | -- | -- | -- | |
P/L Before Tax | 48.96 | 50.08 | 36.35 | 67.00 | 75.35 | |
Tax | 12.25 | 13.50 | 10.00 | 14.00 | 19.50 | |
P/L After Tax from Ordinary Activities | 36.71 | 36.58 | 26.35 | 53.00 | 55.85 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 36.71 | 36.58 | 26.35 | 53.00 | 55.85 | |
Equity Share Capital | 92.60 | 92.60 | 92.60 | 92.60 | 92.60 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 3.96 | 3.95 | 2.85 | 5.72 | 6.03 | |
Diluted EPS | 3.96 | 3.95 | 2.85 | 5.72 | 6.03 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 3.96 | 3.95 | 2.85 | 5.72 | 6.03 | |
Diluted EPS. | 3.96 | 3.95 | 2.85 | 5.72 | 6.03 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
28.01.2023
Aarti Drugs Consolidated December 2022 Net Sales at Rs 663.96 crore, up 4.59% Y-o-Y
27.01.2023
Aarti Drugs Standalone December 2022 Net Sales at Rs 625.53 crore, up 5.45% Y-o-Y
20.10.2022
Aarti Drugs Standalone September 2022 Net Sales at Rs 624.83 crore, up 22.35% Y-o-Y
20.10.2022
Aarti Drugs Consolidated September 2022 Net Sales at Rs 687.72 crore, up 18.65% Y-o-Y
28.01.2023
Aarti Drugs Consolidated December 2022 Net Sales at Rs 663.96 crore, up 4.59% Y-o-Y
27.01.2023
Aarti Drugs Standalone December 2022 Net Sales at Rs 625.53 crore, up 5.45% Y-o-Y
20.10.2022
Aarti Drugs Standalone September 2022 Net Sales at Rs 624.83 crore, up 22.35% Y-o-Y
20.10.2022
Aarti Drugs Consolidated September 2022 Net Sales at Rs 687.72 crore, up 18.65% Y-o-Y